After analysis and evaluation, we found that, in terms of clinical staging, P4HA3 was more highly expressed at higher stages of BLCA, COAD, ESCA, KIRP, READ, STAD, and UVM. The gene discussed is P4HA3; the disease is bladder transitional cell carcinoma.